Skip to main content
. 2024 Oct 21;14(45):32978–32991. doi: 10.1039/d4ra06394e

IC50 values of compounds 3e, 5a, 5b, 5d, erlotinib, and lapatinib against EGFR and HER2.

Compound EGFR inhibition IC50 ± SEM (nM) HER-2 inhibition IC50 ± SEM (nM)
3e 79 ± 5 39 ± 2
5a 71 ± 4 31 ± 2
5b 85 ± 5 47 ± 3
5d 93 ± 5 53 ± 3
Erlotinib 80 ± 5
Lapatinib 26 ± 1